Dr. Danhui Ma, Ph.D., joined the Sipkins Lab in November 2022 as a Postdoctoral Associate. She obtained her Ph.D. in biology from Tsinghua University, China, in 2020. Currently, her research focuses on investigating the impact of dual inhibition of CXCR4 and E-selectin on immune cell trafficking in breast cancer.